You can narrow down the results using the filters
-
Australian Integrated Mental Health Initiative
Expand descriptionThis project aims to apply evidence based health promotion strategies to people with chronic or recurring mental disorders (CRMD) in an attempt to reduce physical risks. Conducted across three streams, intervention trials will focus on (i) People in urban areas or regional centres who require high levels of support to improve outcomes for those in need high support; (ii) patients of primary care practitioners and mental health services in rural towns and regional centres. The rural stream aims to detect and prevent relapse in mental disorders; reduce risk of physical disorders associated with smoking, excessive alcohol use, unhealthy diet and low activity levels. (iii) Indigenous consumers of mental health services in remote areas and examines contrasting models of mental health services and related information systems. The approach incorporates principles and priorities of the 2nd National Mental Health Plan and attempts to increase the capacity of stakeholders to manage CRMD. It is designed to be sustainable and widely applicable. Overall the study seeks to develop and demonstrate sustainable methods of improving mental health outcomes. Strategic priorities include: enhanced responsiveness of practitioners and service systems to the health risks faced by people with chronic or recurring mental disorders.
-
Mechanisms of Action of Glucosamine Hydrochloride / Chondroitin Sulphate (Cosamin￤) and Clinical Response in Osteoarthritis ⿿ a Pilot Study
Expand description -
A pharmacokinetic study to assess the effect of two different formulations of Testosterone Metered Dose (MD) Lotion on the pharmacokinetics of testosterone in hypogonadism
Expand description -
A phase I study to investigate the linearity of fentanyl steady-state pharmacokinetics following dose-escalated multiple applications of a Fentanyl MDTS in healthy male volunteers in pain
Expand description -
A phase I study to compare the bioavailability and pharmacokinetics of fentanyl after administration of a single dose of a Fentanyl MDTS and a Durogesic 25 patch in pain
Expand description -
A Phase I Study to Determine the Pharmacokinetics of Buspirone from a Metered Dose Transdermal System (MDTS) in anxiety
Expand description -
A pharmacokinetic phase I study to assess the bioavailability and pharmacokinetics of Fentanyl from a metered dose transdermal system (MDTS) in pain
Expand description -
A Phase I Study to Determine the Pharmacokinetics of Nestorone Delivered with the Metered Dose Transdermal System (MDTS) in Postmenopausal Women, to be used in contraception
Expand description -
A phase I pharmacokinetic study to compare the steady-state pharmacokinetics of testosterone following application of a Testosterone Metered-Dose Transdermal Spray (MDTS) to the forearm or abdomen in healthy postmenopausal women with low libido and low serum testosterone
Expand description -
A phase I study to compare the steady-state pharmacokinetics of estradiol following application to the abdomen of an Estradiol Metered-Dose Transdermal Spray (MDTS) and Estraderm 50 patches in healthy postmenopausal women, as hormone replacement therapy.
Expand description